New multipotent tetracyclic tacrines with neuroprotective activity
José Marco-Contelles1, Rafael León, Cristóbal de los Ríos
1Laboratorio de Radicales Libres (IQOG, CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain. iqoc21@iqog.csic.es
Bioorganic & Medicinal Chemistry
|September 29, 2006
Summary
New tetracyclic tacrine analogues show significant neuroprotection against cell damage. These compounds selectively inhibit acetylcholinesterase (AChE), potentially preventing beta-amyloid aggregation, making them promising leads for Alzheimer
Area of Science:
- Medicinal Chemistry
- Neuroscience
- Pharmacology
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
- Current treatments offer symptomatic relief but do not halt disease progression.
- Developing novel therapeutics targeting multiple pathological pathways is crucial.
Purpose of the Study:
- To synthesize and biologically evaluate novel multipotent tetracyclic tacrine analogues.
- To assess their neuroprotective, calcium channel blocking, and enzyme inhibitory activities.
- To investigate their potential as anti-Alzheimer's disease agents.
Main Methods:
- Synthesis of novel tetracyclic tacrine analogues (compounds 5-13).
- Evaluation of neuroprotection in neuroblastoma cells against calcium overload and free radical toxicity.
- Assay of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activity.
- Propidium binding experiments to determine binding site on AChE.
Main Results:
- Compounds 7, 8, and 11 demonstrated significant neuroprotective effects.
- These analogues exhibited modest and selective AChE inhibition, with minimal BuChE activity.
- Propidium displacement studies indicated binding to the peripheral anionic site (PAS) of AChE.
- Compound 8 showed efficient neuroprotection and selective AChE inhibition.
Conclusions:
- The synthesized tetracyclic tacrine analogues possess multipotent properties.
- They offer neuroprotection and selective AChE inhibition, suggesting potential to prevent beta-amyloid aggregation.
- These compounds represent promising lead candidates for developing novel anti-Alzheimer's drugs.
